What is the latest COHANCE stock price?
The latest stored price for COHANCE is Rs 457.60 as of 2026-11-16.
COHANCE LIFESCIENCES LTD is a small-cap stock in Healthcare. This Gimli page shows the latest available COHANCE price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for COHANCE is Rs 457.60 as of 2026-11-16.
COHANCE is above 50DMA, above 200DMA. The latest 50DMA is 452.25 and the latest 200DMA is 410.57.
COHANCE has PE -3,109.46, ROE +0.25%, and ROCE +1.23% in Gimli's latest available snapshot.
COHANCE has returned -1.39% over 1 month, +3.85% over 3 months, and -25.65% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 476.65 cr | 47.79 cr | 15.22 cr | 0.40 |
| 2026-06-30 | 422.26 cr | 13.41 cr | -45.20 cr | -0.63 |
| 2026-03-31 | 619.12 cr | 80.33 cr | 8.30 cr | 0.51 |
| 2025-12-31 | 544.55 cr | 96.65 cr | 29.00 cr | 0.96 |
| 2025-09-30 | 555.57 cr | 136.55 cr | 66.40 cr | 1.94 |
| 2025-06-30 | 549.31 cr | 118.08 cr | 48.82 cr | 1.28 |
| 2025-03-31 | 840.42 cr | 225.49 cr | 120.43 cr | 3.16 |
| 2024-12-31 | 307.15 cr | 133.41 cr | n/a | nan |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 2,268.55 cr | 431.61 cr | 179.23 cr | 4.69 |
| 2025-03-31 | 2,608.50 cr | 850.49 cr | 487.34 cr | 12.79 |
| 2024-03-31 | 1,034.06 cr | 467.22 cr | 300.28 cr | 11.80 |
| 2023-03-31 | 1,331.11 cr | 620.53 cr | 411.29 cr | 16.16 |
| 2022-03-31 | 1,508.01 cr | 712.92 cr | 558.10 cr | nan |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 5,729.64 cr | 49.14 cr | 400.49 cr | 4,033.83 cr |
| 2025-03-31 | 3,031.75 cr | 85.40 cr | 279.07 cr | 1,840.64 cr |
| 2024-03-31 | 2,254.91 cr | 47.23 cr | 65.01 cr | 2,050.67 cr |
| 2023-03-31 | 1,965.74 cr | 64.80 cr | 70.34 cr | 1,735.18 cr |
| 2022-03-31 | 1,829.59 cr | 44.56 cr | 97.12 cr | 1,527.18 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 368.32 cr | 148.44 cr | n/a |
| 2025-03-31 | 673.35 cr | 356.55 cr | n/a |
| 2024-03-31 | 384.77 cr | 332.89 cr | n/a |
| 2023-03-31 | 457.20 cr | 171.28 cr | n/a |
| 2022-03-31 | 330.00 cr | 254.81 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +57.48% | +7.71% | +18.86% | +16.93% | +15.95% | +94.56% |
| 2026-06-30 | +57.49% | +6.50% | +20.09% | +18.21% | +15.92% | +94.56% |
| 2026-03-31 | +57.49% | +5.59% | +21.79% | +18.57% | +15.12% | +0.00% |
| 2025-12-31 | +57.49% | +6.02% | +21.57% | +17.36% | +14.92% | +0.00% |
| 2025-09-30 | +57.49% | +6.51% | +20.82% | +16.49% | +15.17% | +0.00% |
| 2025-06-30 | +66.41% | +7.23% | +11.40% | +8.90% | +14.95% | +0.00% |
| 2025-05-09 | +66.41% | +7.38% | +11.02% | +8.65% | +15.18% | +0.00% |
| 2025-03-31 | +50.10% | +11.05% | +16.60% | +13.04% | +22.23% | +0.00% |
| 2024-12-31 | +50.10% | +10.84% | +16.68% | +13.15% | +22.37% | +0.00% |
| 2024-09-30 | +50.10% | +10.70% | +16.94% | +14.12% | +22.25% | +0.00% |
| 2024-06-30 | +50.10% | +9.80% | +17.42% | +14.78% | +22.67% | +0.00% |
| 2024-03-31 | +50.10% | +9.54% | +17.24% | +15.26% | +23.10% | +0.00% |
| 2023-12-31 | +60.00% | +10.14% | +15.94% | +13.40% | +13.91% | +0.00% |
| 2023-09-30 | +60.00% | +10.01% | +14.14% | +12.15% | +15.84% | +0.00% |
| 2023-06-30 | +60.00% | +9.50% | +10.62% | +9.12% | +19.87% | +0.00% |
| 2023-03-31 | +60.00% | +9.47% | +11.43% | +8.56% | +19.10% | +0.00% |
| 2022-12-31 | +60.00% | +8.11% | +11.35% | +8.97% | +20.53% | +0.00% |
| 2022-09-30 | +60.00% | +7.58% | +10.87% | +8.28% | +21.55% | +0.00% |
| 2022-06-30 | +60.00% | +0.00% | +15.45% | n/a | n/a | +0.00% |
| 2022-03-31 | +60.00% | +0.00% | +15.12% | n/a | n/a | +0.00% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
Data snapshot: 2026-11-16. Not investment advice.